These collective findings unequivocally demonstrate that MZT2B silencing elicits robust apoptotic cell death in NSCLC cells through the activation of the intrinsic caspase cascade, without exhibiting similar effects in non-cancerous lung epithelial cells. Here, MZT2B is linked to non-small cell lung carcinoma.